BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Moodys
Harvard Business School
Queensland Health
Dow
Novartis
Daiichi Sankyo
Express Scripts
Argus Health
Fish and Richardson

Generated: January 20, 2018

DrugPatentWatch Database Preview

Claims for Patent: 5,952,323

« Back to Dashboard

Summary for Patent: 5,952,323
Title: Carbapenem antibiotic
Abstract:A pharmaceutical composition is disclosed which contains a compound of formula I: ##STR1## or a pharmaceutically acceptable salt, prodrug or hydrate thereof, in the stabilized form and/or in combination with a carbon dioxide source.
Inventor(s): Zimmerman; Jeffrey A. (Chalfont, PA), Williams; John M. (Belle Mead, NJ), Bergquist; Paul A. (Collegeville, PA), DiMichele; Lisa M. (Berkeley Heights, NJ), DuBost; David C. (Collegeville, PA), Kaufman; Michael J. (New Hope, PA), Sidler; Daniel R. (Whitehouse Station, NJ), Hunke; William A. (Harleysville, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:09/064,426
Patent Claims: 1. A compound represented by the formula II: ##STR8## or a pharmaceutically acceptable salt, prodrug or hydrate thereof.

2. A pharmaceutical composition which is comprised of a compound represented by formula II: ##STR9## or a pharmaceutically acceptable salt, prodrug or hydrate thereof, in combination with a pharmaceutically acceptable carrier.

3. A compound in accordance with claim 1 wherein the pharmaceutically acceptable salt is selected from the group consisting of: ##STR10## wherein X.sup.+ represents a pharmaceutically acceptable cationic group.

4. A method of stabilizing a carbapenem of the formula I: ##STR11## or a pharmaceutically acceptable salt, prodrug or hydrate thereof, comprising adding to the compound a sufficient amount of a carbon dioxide source to form a compound of formula II: ##STR12## or a pharmaceutically acceptable salt, prodrug or hydrate thereof.

5. A method in accordance with claim 4 wherein the carbon dioxide source is selected from carbon dioxide, sodium carbonate and sodium bicarbonate.

6. A method in accordance with claim 5 wherein the carbon dioxide source is selected from sodium carbonate and sodium bicarbonate.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Accenture
Covington
Johnson and Johnson
Dow
US Department of Justice
Moodys
Cipla
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot